Research
Heavily invested in industry leading research
12,700+
Research reports published in 2024
900+
Small-, mid- and large-cap stocks under coverage
50+
Publishing analysts
Macro Research
We empower our investors with focused, best-in-class macro research. Our top-ranked analysts utilize independent processes that provide impartial insights into economic trends, policy actions and political developments.
Specialized research coverage
We publish collaborative, cross-sector research that provides extensive market, industry, and technical research.
BioInsights
The Piper Sandler BioInsights research platform provides in-depth analyses across a diverse range of innovative and emerging therapeutic modalities, novel drug targets and disease states, through monthly thematic reports, expert events, catalyst calendars and more.
News & Insights
Upcoming Conferences
Spring Biopharma
Infrastructure Finance Summit
Global Exchange and Trading Conference
View covered company disclosures. Analysts Transparency Report: Access the history of Piper Sandler analysts’ ratings, price targets and earnings per share estimates for each covered security.
*SMID cap < $5 billion; data as of November 2023. Source: Thomson Reuters.